Machaon Diagnostics is a preferred laboratory partner to pharmaceutical firms conducting clinical trials in the areas of thrombosis, hemostasis, nephology and rare disease. We offer both CAP/CLIA and GLP testing and regulatory-compliant method validation solutions for submission to the FDA and other regulatory bodies. Machaon Diagnostics has emerged as a leading laboratory for complement gene sequencing and other testing, due to our rapid turnaround and expedited study capabilities. Machaon was founded in 2003.
Quidel’s Specialty Products Group is focused on providing innovative research and diagnostic tools for identification of novel markers in autoimmune and Complement. Many of these products are unique in nature and provide researchers and clinicians valuable scientific and diagnostic information. Quidel offers products to meet biosafety testing and Complement dependent cytotoxicity testing requirements, such as normal human sera, proteins, monoclonal and polyclonal antibodies, depleted sera and Complement fragment ELISA assays.